FROM nutraingredients-usa
7/18/2007 - California-based Renaissance Herbs has announced its acquisition by Bangalore-based Avestha Gengraine Technologies Pvt., allowing Renaissance to expand into the EU and Middle East.
The deal, set to be complete by the end of the month, will see Avesthagen purchasing all outstanding shares of Renaissance Herbs company stock, and includes the purchase of Renaissance's Ayurceutics consumer products line,
According to Dr. Villoo Patell, managing director of Avesthagen: "Renaissance Herbs superb manufacturing complex with its ISO 22000:2005, ISO 9001:2000 and organic certifications will allow Avesthagen to actualize our advanced biotechnology research into products for the worldwide nutraceutical and pharma industries."
Wednesday, July 18, 2007
Cary company raising money for biotech VC fund
FROM bizjournals
Cary's Calvert Holdings, a privately held company whose subsidiaries focus on clinical services, is launching a new venture-capital fund - with a twist.
Calvert BioCapital plans to invest in early-stage biopharmaceutical compounds and technologies, the rights of which will be held by a separate entity called Calvert Development.
Another Calvert business, Calvert Laboratories, will develop the compounds through preclinical or phase I trials. Calvert Development will then sub-license the compounds, with investors sharing in the proceeds from the divestment.
Cary's Calvert Holdings, a privately held company whose subsidiaries focus on clinical services, is launching a new venture-capital fund - with a twist.
Calvert BioCapital plans to invest in early-stage biopharmaceutical compounds and technologies, the rights of which will be held by a separate entity called Calvert Development.
Another Calvert business, Calvert Laboratories, will develop the compounds through preclinical or phase I trials. Calvert Development will then sub-license the compounds, with investors sharing in the proceeds from the divestment.
European congress on biotechnology
The 13th European Congress on Biotechnology will take place from 17 to 19 September in Barcelona, Spain.
The event will focus on symbiosis between science, industry and society in the area of biotechnology. The event will analyse the crucial impact that the life sciences industry has had on addressing humanity's greatest challenges; identify remaining and emerging needs; and present the cutting-edge science that will address these new challenges.
Other themes to be covered include industrial biotechnology; health and medicine; green biotechnology; functional genomics and systems biology.
The European Commission is among the sponsors of the event.
For more information, please visit:
http://www.ecb13.eu/
The event will focus on symbiosis between science, industry and society in the area of biotechnology. The event will analyse the crucial impact that the life sciences industry has had on addressing humanity's greatest challenges; identify remaining and emerging needs; and present the cutting-edge science that will address these new challenges.
Other themes to be covered include industrial biotechnology; health and medicine; green biotechnology; functional genomics and systems biology.
The European Commission is among the sponsors of the event.
For more information, please visit:
http://www.ecb13.eu/
Monday, July 16, 2007
India - Govt. Plans to Invest Rs 1,000 Crore in Agri-biotech through PPP
From PR Minds
The Indian government, through Public Private Partnership, has thought of to invest Rs. 1,000 Crore in agri-biotech sector. However, the plan still has to take a physical shape.
The Indian government has ideated to invest Rs 1,000 Crore to develop its agri-biotech sector with the help of Public Private Partnership (PPP), reported a top official of the country’s leading agriculture institute, Indian Agricultural Research Institute (IARI).
However, as per S A Patil, Director, IARI, the plan is in its conceptual stages. He was speaking at the annual biotech fair in Bangalore. Mr. Patil compared the development of agri-biotech sector with that of medical and industrial sectors and said that agri-biotech also needs large investments to foster. And it can be easily achieved through PPP, reports THE FINANCIAL EXPRESS on June 9, 2007.
The Indian government, through Public Private Partnership, has thought of to invest Rs. 1,000 Crore in agri-biotech sector. However, the plan still has to take a physical shape.
The Indian government has ideated to invest Rs 1,000 Crore to develop its agri-biotech sector with the help of Public Private Partnership (PPP), reported a top official of the country’s leading agriculture institute, Indian Agricultural Research Institute (IARI).
However, as per S A Patil, Director, IARI, the plan is in its conceptual stages. He was speaking at the annual biotech fair in Bangalore. Mr. Patil compared the development of agri-biotech sector with that of medical and industrial sectors and said that agri-biotech also needs large investments to foster. And it can be easily achieved through PPP, reports THE FINANCIAL EXPRESS on June 9, 2007.
Subscribe to:
Posts (Atom)